Your browser doesn't support javascript.
loading
Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth.
Roskin, Krishna M; Jackson, Katherine J L; Lee, Ji-Yeun; Hoh, Ramona A; Joshi, Shilpa A; Hwang, Kwan-Ki; Bonsignori, Mattia; Pedroza-Pacheco, Isabela; Liao, Hua-Xin; Moody, M Anthony; Fire, Andrew Z; Borrow, Persephone; Haynes, Barton F; Boyd, Scott D.
Afiliação
  • Roskin KM; Department of Pediatrics, University of Cincinnati, College of Medicine, Cincinnati, OH, USA.
  • Jackson KJL; Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Lee JY; Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Hoh RA; Department of Immunology, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Joshi SA; Department of Pathology, Stanford University, Stanford, CA, USA.
  • Hwang KK; Department of Pathology, Stanford University, Stanford, CA, USA.
  • Bonsignori M; Department of Pathology, Stanford University, Stanford, CA, USA.
  • Pedroza-Pacheco I; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Liao HX; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Moody MA; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
  • Fire AZ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Borrow P; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Haynes BF; Department of Pathology, Stanford University, Stanford, CA, USA.
  • Boyd SD; Department of Genetics, Stanford University, Stanford, CA, USA.
Nat Immunol ; 21(2): 199-209, 2020 02.
Article em En | MEDLINE | ID: mdl-31959979
ABSTRACT
A goal of HIV vaccine development is to elicit antibodies with neutralizing breadth. Broadly neutralizing antibodies (bNAbs) to HIV often have unusual sequences with long heavy-chain complementarity-determining region loops, high somatic mutation rates and polyreactivity. A subset of HIV-infected individuals develops such antibodies, but it is unclear whether this reflects systematic differences in their antibody repertoires or is a consequence of rare stochastic events involving individual clones. We sequenced antibody heavy-chain repertoires in a large cohort of HIV-infected individuals with bNAb responses or no neutralization breadth and uninfected controls, identifying consistent features of bNAb repertoires, encompassing thousands of B cell clones per individual, with correlated T cell phenotypes. These repertoire features were not observed during chronic cytomegalovirus infection in an independent cohort. Our data indicate that the development of numerous B cell lineages with antibody features associated with autoreactivity may be a key aspect in the development of HIV neutralizing antibody breadth.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Anticorpos Anti-HIV / Infecções por HIV / Vacinas contra a AIDS / Anticorpos Amplamente Neutralizantes Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Anticorpos Anti-HIV / Infecções por HIV / Vacinas contra a AIDS / Anticorpos Amplamente Neutralizantes Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article